From Barchart: 2024-11-05 04:05:38

Hologic, Inc. (NASDAQ:HOLX) reported Q4 2024 earnings with an EPS of $1.01, meeting estimates. Revenue of $987.9 million exceeded expectations, indicating strong sales performance. Financial ratios like P/E ratio of 24.79 and current ratio of 3.69 highlight Hologic’s solid financial standing and market valuation in the healthcare industry.



Read more at Barchart:: Hologic, Inc. (NASDAQ:HOLX) Q4 2024 Earnings Overv…